Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D2-like receptor stimulation

Psychopharmacology

Volumn 187, Issue 3, 2006, Pages 303-311

  Basselin, Mireille ^a   Chang, Lisa ^a   Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Bipolar disorder; Brain; Dopamine D2 receptor; Glucose metabolism; Lithium; Quinpirole

Indexed keywords

DEOXYGLUCOSE; DOPAMINE 2 RECEPTOR; GLUCOSE; LITHIUM CHLORIDE; QUINPIROLE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUDITORY SYSTEM; BIPOLAR DISORDER; BRAIN REGION; CAUDATE NUCLEUS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET; DRUG BLOOD LEVEL; DRUG POTENTIATION; FRONTAL CORTEX; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HIPPOCAMPUS; INTERPEDUNCULAR NUCLEUS; LONG TERM EXPOSURE; MALE; METABOLIC RATE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RAT; RECEPTOR UPREGULATION; SUBSTANTIA NIGRA; VISUAL SYSTEM;

ANIMALS; BRAIN; DRUG SYNERGISM; GLUCOSE; LITHIUM CHLORIDE; MALE; QUINPIROLE; RATS; RATS, INBRED F344; RECEPTORS, DOPAMINE D2;

EID: 33746032585     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0425-0     Document Type: Article

References (58)

1. Altshuler LL, Bookheimer SY, Townsend J, Proenza MA, Eisenberger N, Sabb F, Mintz J, Cohen MS (2005) Blunted activation in orbitofrontal cortex during mania: a functional magnetic resonance imaging study. Biol Psychiatry 58:763-769
2. Arnauld E, Jeantet Y, Arsaut J, Demotes-Mainard J (1996) Involvement of the caudal striatum in auditory processing: c-fos response to cortical application of picrotoxin and to auditory stimulation. Brain Res Mol Brain Res 41:27-35
3. Basselin M, Chang L, Bell J, Rapoport SI (2005) Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor initiated signaling via arachidonic acid. Neuropsychopharmacology 30:1064-1075
4. Basselin M, Chang L, Seemann R, Bell JM, Rapoport SI (2003) Chronic lithium administration potentiates brain arachidonic acid signaling at rest and during cholinergic activation in awake rats. J Neurochem 85:1553-1562
5. Bauer M, Alda M, Priller J, Young LT (2003) Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Pharmacopsychiatry 36(Suppl 3):S250-S254
6. Baxter LR Jr, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, Sumida RM (1985) Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch Gen Psychiatry 42:441-447
7. Bhattacharjee AK, Chang L, Lee HJ, Bazinet RP, Seemann R, Rapoport SI (2005) D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats. Psychopharmacology (Berl) 180:735-742
8. Bosetti F, Seemann R, Bell JM, Zahorchak R, Friedman E, Rapoport SI, Manickam P (2002) Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration. Brain Res Bull 57:205-209
9. Brodai A (1981) Neurological anatomy in relation to clinical medicine, 3rd edn. Oxford University Press, London, UK
10. Bymaster FP, Felder CC (2002) Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents. Mol Psychiatry 7(Suppl 1):S57-S63
11. Calabrese JR, Bowden C, Woyshville MJ (1995) Lithium and the anticonvulsants in the treatment of bipolar disorder. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven, New York, pp 1099-1111
12. Carlson PJ, Singh JB, Zarate CA Jr, Drevets WC, Manji HK (2006) Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx 3:22-41
13. Carpenter TL, Pazdernik TL, Levant B (2003) Differences in quinpirole-induced local cerebral glucose utilization between naive and sensitized rats. Brain Res 964:295-301
14. Chang K, Adleman NE, Dienes K, Simeonova DI, Menon V, Reiss A (2004) Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Arch Gen Psychiatry 61:781-792
15. Clarke RJ, Blanks RH, Giolli RA (2003) Midbrain connections of the olivary pretectal nucleus in the marmoset (Callithrix jacchus): implications for the pupil light reflex pathway. Anat Embryol (Berl) 207:149-155
16. Dziedzicka-Wasylewska M, Wedzony K (1996) The effect of prolonged administration of lithium on the level of dopamine D2 receptor mRNA in the rat striatum and nucleus accumbens. Acta Neurobiol Exp (Wars) 56:29-34
17. Ehlert FJ, Tran LP (1990) Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain. J Pharmacol Exp Ther 255:1148-1157
18. Ferrie L, Young AH, McQuade R (2005) Effect of chronic lithium and withdrawal from chronic lithium on presynaptic dopamine function in the rat. J Psychopharmacol 19:229-234
19. Gaillard WD, Zeffiro T, Fazilat S, DeCarli C, Theodore WH (1996) Effect of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 15O water positron emission tomography study. Epilepsia 37:515-521
20. Gambarana C, Ghiglieri O, Masi F, Scheggi S, Tagliamonte A, De Montis MG (1999) The effects of long-term administration of rubidium or lithium on reactivity to stress and on dopamine output in the nucleus accumbens in rats. Brain Res 826:200-209
21. Ghadirian AM, Annable L, Belanger MC, Chouinard G (1996) A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients. J Clin Psychiatry 57:22-28
22. Goetz CG (1997) New strategies with dopaminergic drugs: modified formulations of levodopa and novel agonists. Exp Neurol 144:17-20
23. Hegerl U, Herrmann WM, Ulrich G, Muller-Oerlinghausen B (1990) Effects of lithium on auditory evoked potentials in healthy subjects. Biol Psychiatry 27:555-560
24. Hosey LA, Thompson JL, Metman LV, van den Munckhof P, Braun AR (2005) Temporal dynamics of cortical and subcortical responses to apomorphine in Parkinson disease: an H2(15)O PET study. Clin Neuropharmacol 28:18-27
25. Janowsky DS, Overstreet DH (1995) The role of acetylcholine mechanisms in mood disorders. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology. The fourth generation of progress. Raven, New York, pp 945-956
26. Jung H, Reme C (1994) Light-evoked arachidonic acid release in the retina: illuminance/duration dependence and the effects of quinacrine, mellitin and lithium. Light-evoked arachidonic acid release. Graefes Arch Clin Exp Ophthalmol 232:167-175
27. Kato M, Lledo PM, Vincent JD (1991) Blockade by lithium ions of potassium channels in rat anterior pituitary cells. Am J Physiol 261:C218-C223
28. Ketter TA, Kimbrell TA, George MS, Willis MW, Benson BE, Danielson A, Frye MA, Herscovitch P, Post RM (1999) Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders. Biol Psychiatry 46:1364-1374
29. 11C-glucose metabolism in manic and depressed patients. Psychiatry Res 22:81-88
30. Levant B, Grigoriadis DE, DeSouza EB (1993) [3H]Quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study. J Pharmacol Exp Ther 264:991-1001
31. Malmberg A, Mohell N (1995) Characterization of [3H]quinpirole binding to human dopamine D2A and D3 receptors: effects of ions and guanine nucleotides. J Pharmacol Exp Ther 274:790-797
32. Mazziotta JC, Phelps ME, Carson RE, Kuhl DE (1982) Tomographic mapping of human cerebral metabolism: auditory stimulation. Neurology 32:921-937
33. Nagy A, Paroczy Z, Norita M, Benedek G (2005) Multisensory responses and receptive field properties of neurons in the substantia nigra and in the caudate nucleus. Eur J Neurosci 22:419-424
34. Neve KA, Seamans JK, Trantham-Davidson H (2004) Dopamine receptor signaling. J Recept Signal Transduct Res 24:165-205
35. Oestreicher E, Arnold W, Ehrenberger K, Felix D (1997) Dopamine regulates the glutamatergic inner hair cell activity in guinea pigs. Hear Res 107:46-52
36. Ormandy GC, Song L, Jope RS (1991) Analysis of the convulsant- potentiating effects of lithium in rats. Exp Neurol 111:356-361
37. Paxinos G, Watson C (1987) The rat brain in stereotaxic coordinates, 2nd edn. Academic, New York
38. Pfeilschifter J, Reme C, Dietrich C (1988) Light-induced phosphoinositide degradation and light-induced structural alterations in the rat retina are enhanced after chronic lithium treatment. Biochem Biophys Res Commun 156:1111-1119
39. Phelps ME, Mazziotta JC, Kuhl DE, Nuwer M, Packwood J, Metter J, Engel Jr J (1981) Tomographic mapping of human cerebral metabolism: visual stimulation and deprivation. Neurology 31:517-529
40. Pizzolato G, Soncrant TT, Larson DM, Rapoport SI (1987) Stimulatory effect of the D2 antagonist sulpiride on glucose utilization in dopaminergic regions of rat brain. J Neurochem 49:631-638
41. Pizzolato G, Soncrant TT, Rapoport SI (1985) Time-course and regional distribution of the metabolic effects of bromocriptine in the rat brain. Brain Res 341:303-312
42. Pollmann S, Lepsien J, Hugdahl K, von Cramon DY (2004) Auditory target detection in dichotic listening involves the orbitofrontal and hippocampal paralimbic belts. Cereb Cortex 14:903-913
43. Post RM, Jimerson DC, Bunney WE Jr, Goodwin FK (1980) Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology (Berl) 67:297-305
44. Quiroz JA, Gould TD, Manji HK (2004) Molecular effects of lithium. Mol Interv 4:259-272
45. Rapoport SI (1976) Blood-brain barrier in physiology and medicine. Raven, New York
46. Rapoport SI (2001) In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling. J Mol Neurosci 16:243-261
47. Roane DS, Paul D (1992) Evidence of hyperglycemic hyperalgesia by quinpirole. Pharmacol Biochem Behav 41:65-67
48. Rodriguez-Gil JE, Fernandez-Novell JM, Barbera A, Guinovart JJ (2000) Lithium's effects on rat liver glucose metabolism in vivo. Arch Biochem Biophys 375:377-384
49. Rowe MK, Chuang DM (2004) Lithium neuroprotection: molecular mechanisms and clinical implications. Expert Rev Mol Med 6:1-18
50. Sokoloff L (1999) Energetics of functional activation in neural tissues. Neurochem Res 24:321-329
51. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M (1977) The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 28:897-916
52. Soncrant TT, Holloway HW, Greig NH, Rapoport SI (1989) Regional brain metabolic responsivity to the muscarinic cholinergic agonist arecoline is similar in young and aged Fischer-344 rats. Brain Res 487:255-266
53. Storlien LH, Higson FM, Gleeson RM, Smythe GA, Atrens DM (1985) Effects of chronic lithium, amitriptyline and mianserin on glucoregulation, corticosterone and energy balance in the rat. Pharmacol Biochem Behav 22:119-125
54. Tabachnick BG, Fidell LS (2001) Computer assisted research design and analysis. Allyn and Bacon, Boston, MA
55. Takei H, Fredericks WR, Rapoport SI (1986) The lumped constant in the deoxyglucose procedure declines with age in Fischer-344 rats. J Neurochem 46:931-938
56. Teixeira NA, Karniol IG (1982) The influence of age and sex on weight variation in rats treated chronically with lithium chloride. Acta Pharmacol Toxicol (Copenh) 51:1-5
57. Ulrich G, Herrmann WM, Hegerl U, Muller-Oerlinghausen B (1990) Effect of lithium on the dynamics of electroencephalographic vigilance in healthy subjects. J Affect Disord 20:19-25
58. Uvnas-Moberg K, Ahlenius S, Alster P, Hillegaart V (1996) Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat. Neuroendocrinology 63:269-274